1. Academic Validation
  2. Pharmacological potentiators of the calcium signaling cascade identified by high-throughput screening

Pharmacological potentiators of the calcium signaling cascade identified by high-throughput screening

  • PNAS Nexus. 2022 Dec 9;2(1):pgac288. doi: 10.1093/pnasnexus/pgac288.
Michele Genovese 1 Daniela Guidone 1 Martina Buccirossi 1 Anna Borrelli 1 Alejandra Rodriguez-Gimeno 2 Fabio Bertozzi 2 Tiziano Bandiera 2 Luis J V Galietta 1 3
Affiliations

Affiliations

  • 1 Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, 80078 Naples, Italy.
  • 2 D3 PharmaChemistry, Italian Institute of Technology (IIT), Via Morego, 3016163, Genoa, Italy.
  • 3 Department of Translational Medical Sciences (DISMET), Università degli Studi di Napoli "Federico II, C.so Umberto I, 40, 80138 Napoli NA, Italy.
Abstract

Pharmacological modulators of the CA2+ signaling cascade are important research tools and may translate into novel therapeutic strategies for a series of human diseases. We carried out a screening of a maximally diverse chemical library using the CA2+-sensitive Cl- channel TMEM16A as a functional readout. We found compounds that were able to potentiate UTP-dependent TMEM16A activation. Mechanism of action of these compounds was investigated by a panel of assays that looked at intracellular CA2+ mobilization triggered by extracellular agonists or by caged-IP3 photolysis, PIP2 breakdown by Phospholipase C, and ion channel activity on nuclear membrane. One compound appears as a selective potentiator of inositol triphosphate receptor type 1 (ITPR1) with a possible application for some forms of spinocerebellar ataxia. A second compound is instead a potentiator of the P2RY2 purinergic receptor, an activity that could promote fluid secretion in dry eye and chronic obstructive respiratory diseases.

Keywords

calcium signaling; high throughput screening; inositol triphosphate receptor; phospholipase C; purinergic receptor.

Figures
Products